Detalhe da pesquisa
1.
Magnetic resonance linear accelerator technology and adaptive radiation therapy: An overview for clinicians.
CA Cancer J Clin
; 72(1): 34-56, 2022 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34792808
2.
The Use of Magnetic Resonance Imaging in Radiation Therapy Treatment Simulation and Planning.
J Magn Reson Imaging
; 2024 Jan 24.
Artigo
Inglês
| MEDLINE | ID: mdl-38265188
3.
Bladder Cancer, Version 3.2024.
J Natl Compr Canc Netw
; 22(4): 216-225, 2024 05.
Artigo
Inglês
| MEDLINE | ID: mdl-38754471
4.
Impact of PSMA PET on Prostate Cancer Management.
Curr Treat Options Oncol
; 25(2): 191-205, 2024 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-38270802
5.
Implications of metastatic stage at presentation in docetaxel naïve metastatic castrate resistant prostate cancer.
Prostate
; 83(10): 912-921, 2023 07.
Artigo
Inglês
| MEDLINE | ID: mdl-37071764
6.
A novel prostate cancer subtyping classifier based on luminal and basal phenotypes.
Cancer
; 129(14): 2169-2178, 2023 07 15.
Artigo
Inglês
| MEDLINE | ID: mdl-37060201
7.
LUNAR: a randomized Phase 2 study of 177 Lutetium-PSMA Neoadjuvant to Ablative Radiotherapy for Oligorecurrent Prostate Cancer (clinical trial protocol).
BJU Int
; 132(1): 65-74, 2023 07.
Artigo
Inglês
| MEDLINE | ID: mdl-36797449
8.
Association of PSA kinetics after testosterone recovery with subsequent recurrence: secondary analysis of a phase III randomized controlled trial.
World J Urol
; 41(12): 3905-3911, 2023 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-37792009
9.
Multimodality Therapies for Localized Prostate Cancer.
Curr Oncol Rep
; 25(3): 221-229, 2023 03.
Artigo
Inglês
| MEDLINE | ID: mdl-36723856
10.
Selecting the optimal radiation modality in prostate cancer.
Clin Adv Hematol Oncol
; 21(9): 494-501, 2023 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-37647496
11.
Androgen deprivation therapy use and duration with definitive radiotherapy for localised prostate cancer: an individual patient data meta-analysis.
Lancet Oncol
; 23(2): 304-316, 2022 02.
Artigo
Inglês
| MEDLINE | ID: mdl-35051385
12.
Pan-cancer analysis of prognostic metastatic phenotypes.
Int J Cancer
; 150(1): 132-141, 2022 01 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34287840
13.
Genomic biomarkers to guide precision radiotherapy in prostate cancer.
Prostate
; 82 Suppl 1: S73-S85, 2022 08.
Artigo
Inglês
| MEDLINE | ID: mdl-35657158
14.
Intermediate clinical endpoints for surrogacy in localised prostate cancer: an aggregate meta-analysis.
Lancet Oncol
; 22(3): 402-410, 2021 03.
Artigo
Inglês
| MEDLINE | ID: mdl-33662287
15.
False positive PSMA PET for tumor remnants in the irradiated prostate and other interpretation pitfalls in a prospective multi-center trial.
Eur J Nucl Med Mol Imaging
; 48(2): 501-508, 2021 02.
Artigo
Inglês
| MEDLINE | ID: mdl-32808077
16.
Phase 3 multicenter randomized trial of PSMA PET/CT prior to definitive radiation therapy for unfavorable intermediate-risk or high-risk prostate cancer [PSMA dRT]: study protocol.
BMC Cancer
; 21(1): 512, 2021 May 07.
Artigo
Inglês
| MEDLINE | ID: mdl-33962579
17.
Magnetic resonance imaging-guided stereotactic body radiotherapy for prostate cancer (mirage): a phase iii randomized trial.
BMC Cancer
; 21(1): 538, 2021 May 11.
Artigo
Inglês
| MEDLINE | ID: mdl-33975579
18.
A personalized decision aid for prostate cancer shared decision making.
BMC Med Inform Decis Mak
; 21(1): 374, 2021 12 31.
Artigo
Inglês
| MEDLINE | ID: mdl-34972513
19.
Clinical assessment of geometric distortion for a 0.35T MR-guided radiotherapy system.
J Appl Clin Med Phys
; 22(8): 303-309, 2021 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-34231963
20.
18F-fluciclovine PET-CT and 68Ga-PSMA-11 PET-CT in patients with early biochemical recurrence after prostatectomy: a prospective, single-centre, single-arm, comparative imaging trial.
Lancet Oncol
; 20(9): 1286-1294, 2019 09.
Artigo
Inglês
| MEDLINE | ID: mdl-31375469